Actio Biosciences, Inc.
Cayce Denton is an accomplished finance professional with extensive experience in leadership roles across various investment and biotechnology firms. Currently serving as the Chief Financial Officer at Actio Biosciences, Inc., Cayce has previously held positions as General Partner at Dandelion Capital Management, Director at Temasek, and Vice President at TPG Biotech. This diverse background reflects a strong capability in financial management and strategic investment within the biotech sector.
This person is not in any teams
This person is not in any offices
Actio Biosciences, Inc.
We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients.